Zobrazeno 1 - 10
of 32
pro vyhledávání: '"for the PROMISE study team"'
Autor:
Katie E. J. Hann, Lindsay Fraser, Lucy Side, Sue Gessler, Jo Waller, Saskia C. Sanderson, Madeleine Freeman, Ian Jacobs, Anne Lanceley, for the PROMISE study team
Publikováno v:
BMC Women's Health, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Ovarian cancer is usually diagnosed at a late stage when outcomes are poor. Personalised ovarian cancer risk prediction, based on genetic and epidemiological information and risk stratified management in adult women could improve
Externí odkaz:
https://doaj.org/article/d60a3ee75bdb487b8f19ede5d5b7ae71
Autor:
Katie E. J. Hann, Madeleine Freeman, Lindsay Fraser, Jo Waller, Saskia C. Sanderson, Belinda Rahman, Lucy Side, Sue Gessler, Anne Lanceley, for the PROMISE study team
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-30 (2017)
Abstract Background Genetic testing for risk of hereditary cancer can help patients to make important decisions about prevention or early detection. US and UK studies show that people from ethnic minority groups are less likely to receive genetic tes
Externí odkaz:
https://doaj.org/article/a25d602f29964165953cb53aec831d44
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lynda Stranix-Chibanda, Camlin Tierney, Mauricio Pinilla, Kathleen George, Jim Aizire, Godwin Chipoka, Macpherson Mallewa, Megeshinee Naidoo, Teacler Nematadzira, Bangani Kusakara, Avy Violari, Tapiwa Mbengeranwa, Boniface Njau, Lee Fairlie, Gerard Theron, Mwangelwa Mubiana-Mbewe, Sandhya Khadse, Renee Browning, Mary Glenn Fowler, George K Siberry, PROMISE Study Team
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0255250 (2021)
BackgroundMalnutrition is highly prevalent in HIV-exposed perinatally uninfected infants (HEUs) increasing the risk of morbidity and mortality throughout the life course. We set out to compare the effect of postnatal exposure to maternal antiretrovir
Externí odkaz:
https://doaj.org/article/5b581a728ea141ebaf83676047605aad
Autor:
Nematadzira, Teacler G, Murnane, Pamela M, Odiase, Osamuedeme J, Bacchetti, Peter, Okochi, Hideaki, Tallerico, Regina, Chanaiwa, Vongai M, Vhembo, Tichaona, Mutambanengwe-Jacob, Mercy T, Louie, Alexander, Chipato, Tsungai, Gandhi, Monica, Stranix-Chibanda, Lynda, IMPAACT PROMISE Study Team
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), vol 91, iss 3
BackgroundWe examined change in antiretroviral treatment (ART) adherence after breastfeeding (BF) cessation using hair tenofovir (TFV) concentrations as an objective metric of medication consumption.MethodsA subset of postpartum women in Zimbabwe ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::ce50b58cad112083405da71c5cc4190e
https://escholarship.org/uc/item/1qw5w0g0
https://escholarship.org/uc/item/1qw5w0g0
Autor:
Sean S Brummel, Gift Chareka, Neetal Nevrekar, Dhayendre Moodley, Judith S. Currier, Michael Basar, Renee Browning, Taha E. Taha, Kathleen George, Lee Fairlie, Tichaona Vhembo, Konstantia Angelidou, Nahida Chakhtoura, Patience Atuhaire, Pendo Mlay, Allen Matubu, Dingase Dula, FF Promise Study Team, Impaact Promise Bf, Gerhard Theron, Friday Saidi, Mary Glenn Fowler
Publikováno v:
J Acquir Immune Defic Syndr
IMPAACT PROMISE 1077BF/FF was a sequentially randomized study of pregnant and postpartum women living with HIV to investigate the efficacy and safety of antiretroviral therapy (ART). This Maternal Health Component investigated efficacy for the risk o
Autor:
Mark Mirochnick, Mae Cababasay, Mary Glenn Fowler, Jim Aizire, Kristina M Brooks, Kevin Butler, Promise study team, Jennifer J. Kiser, Terry Fenton, George K. Siberry, Patricia M. Flynn
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 83:173-180
Background In the Promoting Maternal and Infant Survival Everywhere (PROMISE) trial, tenofovir disoproxil fumarate (TDF) use was associated with moderate or severe adverse pregnancy/neonatal outcomes. This study characterized tenofovir diphosphate (T
Autor:
Daisy Ko, Mary Glenn Fowler, Maxensia Owor, Lynda Stranix-Chibanda, Ceejay L Boyce, Infant Survival Everywhere (Promise) Study Team, Taha E. Taha, Impaact Bf Promoting Maternal, Patricia DeMarrais, Sheila Styrchak, Ingrid A. Beck, Patricia M. Flynn, Lisa M. Frenkel, Annie Wong-On-Wing, Tatiana Sils, Camlin Tierney
Publikováno v:
Clin Infect Dis
Background We aimed to assess if maternal human immunodeficiency virus (HIV) drug resistance is associated with an increased risk of HIV vertical transmission and to describe the dynamics of drug resistance in HIV-infected infants. Methods This was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351ddc5bb360ca46cbbc7d0b927a8e2a
https://europepmc.org/articles/PMC9187323/
https://europepmc.org/articles/PMC9187323/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.